A study published in the British Medical Journal found that women who use birth-control pills made with the hormone drospirenone are three times more likely to develop blood clots than those who take older oral contraceptives.
Researchers selected nearly 300 women aged 15 to 44 who did not have any major risk factors for blood clots to participate in the study. Sixty-one of those women who started using contraceptives after May 2002 had been diagnosed with clots, the researchers found.
Although the overall risk of developing a clot in the lungs or legs was still low for women using drospirenone according to the study, the results supported earlier findings from European studies. In those studies, researchers from U.S. and New Zealand concluded that drospirenone appears to have a higher risk of clots compared with the older hormone levonorgestrel.
Bayer AG’s Yasmin, Beyaz, Yaz and Angeliq pills all contain drospirenone. As of February 1, there were about 6,850 U.S. lawsuits pending over alleged injuries and deaths as a result of the use of Yasmin, Yaz, or Teva’s generic versions of the drugs, according to Bayer’s annual report. Bayer also faces 13 class action suits in Canada.
The attorneys at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries. Our skilled team of attorneys has successfully pursued litigation and obtained verdicts and settlements for victims of pharmaceutical injuries. If you or a loved one has suffered serious injuries as a result of taking birth-control pills, please contact us at 1-877-MessaLaw.
No comments:
Post a Comment